Are new treatments for celiac disease on the horizon?
Summary
Dr. Maureen Leonard discusses celiac disease, explaining its immune-mediated nature and the mystery of its unpredictable onset. She highlights promising new therapies, including the drug TEV-408, which aims to block inflammation and protect the intestine from gluten damage. Leonard also shares insights from a long-term birth cohort study tracking environmental and microbiome factors that may trigger the disease in at-risk children.
Topics discussed
Sponsor: Audible Theater's 'A Ghost in Your Ear'
Sponsor: NYU Scarball's 'Tom at the Farm'
Sponsor: Progressive Insurance
Intro: Celiac disease overview and guest introduction
Explaining the mechanism of celiac disease
Why celiac disease triggers at different times in life
New drug TEV-408 and its clinical trial results
Other potential treatments in the pipeline
Birth cohort study to identify early celiac markers
Timeline for new treatments and diagnosis importance
Testing recommendations for family members
Discussion on historical wheat varieties and gluten intake
Closing remarks and guest credits
Sponsor: Brooklyn SolarWorks
Sponsor: NYC Campaign Finance Board
Listen ad-free on Castria